ADIPOQ and early-onset autosomal dominant Alzheimer disease: One (The Framingham Heart Study) showed that increased baseline adiponectin levels were a significant risk factor for later Alzheimer’s disease in women, and another found higher levels of adiponectin in Japanese subjects with Alzheimer’s disease, along with a positive correlation between plasma and cerebrospinal fluid (CSF) adiponectin.